Title	Publication Date	Language	Citations
Recall memory deficit in schizophrenia	1989/05/01	English	148
The relation between objective and subjective domains of recovery among persons with schizophrenia-related disorders	2011/09/01	English	147
Deficit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders	2007/08/01	English	147
Motivation and its Relationship to Neurocognition, Social Cognition, and Functional Outcome in Schizophrenia	2009/11/01	English	146
A large-scale validation study of the Medication Adherence Rating Scale (MARS)	2008/03/01	English	146
Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling	2016/09/01	English	146
Stress and protective factors in individuals at ultra-high risk for psychosis, first episode psychosis and healthy controls	2011/06/01	English	145
Increased brain d-amino acid oxidase (DAAO) activity in schizophrenia	2008/04/01	English	145
Stigma moderates the associations of insight with depressed mood, low self-esteem, and low quality of life in patients with schizophrenia spectrum disorders	2009/12/01	English	145
Remission in early psychosis: Rates, predictors, and clinical and functional outcome correlates	2007/01/01	English	145
Reduced cortical thickness in first episode schizophrenia	2010/02/01	English	145
Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis	2009/04/01	English	145
Semantic priming in thought disordered schizophrenic patients	1988/01/01	English	145
Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia	2009/03/01	English	144
Common variants conferring risk of schizophrenia: A pathway analysis of GWAS data	2010/09/01	English	144
Evoked gamma band synchronization and the liability for schizophrenia*1	2004/10/01	English	144
Substance use: a powerful predictor of relapse in schizophrenia	1996/05/01	English	144
Mortality in schizophrenia and schizoaffective disorder: An Olmsted County, Minnesota cohort: 1950–2005	2008/01/01	English	144
The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder	2008/03/01	English	143
Factor structure of the brief negative symptom scale	2012/12/01	English	143
Predictors and profiles of treatment non-adherence and engagement in services problems in early psychosis	2008/07/01	English	143
The relationship between duration of untreated psychosis and outcome: An eight-year prospective study	2005/11/01	English	142
Risk of symptom recurrence with medication discontinuation in first-episode psychosis: A systematic review	2014/02/01	English	142
How can the brain's resting state activity generate hallucinations? A ‘resting state hypothesis’ of auditory verbal hallucinations	2011/04/01	English	142
A dimensional approach to the psychosis spectrum between bipolar disorder and schizophrenia: The Schizo-Bipolar Scale	2011/12/01	English	142
Clinical symptoms, mainly negative symptoms, mediate the influence of neurocognition and social cognition on functional outcome of schizophrenia	2013/05/01	English	142
Cerebral grey, white matter and csf in never-medicated, first-episode schizophrenia	2007/01/01	English	141
Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: Results of the CLAMORS Study	2007/02/01	English	141
Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial	2011/02/01	English	141
Intrinsic motivation, neurocognition and psychosocial functioning in schizophrenia: Testing mediator and moderator effects	2008/10/01	English	141